These findings indicate that, at the level of whole-tissue protein content, upregulation of the TIGIT/CD155 axis appears to be a relatively common feature of CRC that does not segregate with conventional indicators of tumor stage. The gene discussed is PVR; the disease is colorectal carcinoma.